Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer

Emanuela Flamini, Laura Mercatali, Oriana Nanni, Daniele Calistri, Roberta Nunziatini, Wainer Zoli, Paola Rosetti, Nice Gardini, Arturo Lattuneddu, Giorgio Maria Verdecchia, Dino Amadori

Research output: Contribution to journalArticle

Abstract

Purpose: The identification of new molecular markers for the early detection of colorectal cancer has become an important objective. We compared the sensitivity and specificity of free circulating DNA with that of the more conventional carcinoembryonic antigen (CEA) and evaluated the two markers in combination. Experimental Design: The study was carried out on 75 healthy donors and 75 colorectal cancer patients. Free DNA was determined in serum with quantitative PCR analysis. The diagnostic accuracy of each assay was calculated using receiver operating characteristic (ROC) curves. The diagnostic relevance of the two-marker combination was analyzed by the logistic regression model. Results: Median free DNA concentration was ∼5-fold higher in patients than in healthy donors (P <0.001). The area under the ROC curve was 0.86, and when 12.5 ng/mL was used as cutoff, 81.3% sensitivity and 73.3% specificity were observed for the overall series. As CEA and free DNA provided independent diagnostic information, they were also considered in combination. ROC curve analysis of the combined CEA and free DNA algorithms showed a higher diagnostic capacity (area under the ROC curve, 0.92) than that of markers considered singly, with 84% sensitivity and 88% specificity. Conclusions: Free circulating DNA, especially when used in combination with CEA, represents a potentially useful tool for the diagnosis of early-stage colorectal cancer.

Original languageEnglish
Pages (from-to)6985-6988
Number of pages4
JournalClinical Cancer Research
Volume12
Issue number23
DOIs
Publication statusPublished - Dec 1 2006

Fingerprint

Carcinoembryonic Antigen
Colorectal Neoplasms
ROC Curve
DNA
Serum
Sensitivity and Specificity
Logistic Models
Tissue Donors
Early Detection of Cancer
Research Design
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Free DNA and carcinoembryonic antigen serum levels : An important combination for diagnosis of colorectal cancer. / Flamini, Emanuela; Mercatali, Laura; Nanni, Oriana; Calistri, Daniele; Nunziatini, Roberta; Zoli, Wainer; Rosetti, Paola; Gardini, Nice; Lattuneddu, Arturo; Verdecchia, Giorgio Maria; Amadori, Dino.

In: Clinical Cancer Research, Vol. 12, No. 23, 01.12.2006, p. 6985-6988.

Research output: Contribution to journalArticle

Flamini, E, Mercatali, L, Nanni, O, Calistri, D, Nunziatini, R, Zoli, W, Rosetti, P, Gardini, N, Lattuneddu, A, Verdecchia, GM & Amadori, D 2006, 'Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer', Clinical Cancer Research, vol. 12, no. 23, pp. 6985-6988. https://doi.org/10.1158/1078-0432.CCR-06-1931
Flamini, Emanuela ; Mercatali, Laura ; Nanni, Oriana ; Calistri, Daniele ; Nunziatini, Roberta ; Zoli, Wainer ; Rosetti, Paola ; Gardini, Nice ; Lattuneddu, Arturo ; Verdecchia, Giorgio Maria ; Amadori, Dino. / Free DNA and carcinoembryonic antigen serum levels : An important combination for diagnosis of colorectal cancer. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 23. pp. 6985-6988.
@article{0bb33343e462446e96fbfbe5f9e2deb9,
title = "Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer",
abstract = "Purpose: The identification of new molecular markers for the early detection of colorectal cancer has become an important objective. We compared the sensitivity and specificity of free circulating DNA with that of the more conventional carcinoembryonic antigen (CEA) and evaluated the two markers in combination. Experimental Design: The study was carried out on 75 healthy donors and 75 colorectal cancer patients. Free DNA was determined in serum with quantitative PCR analysis. The diagnostic accuracy of each assay was calculated using receiver operating characteristic (ROC) curves. The diagnostic relevance of the two-marker combination was analyzed by the logistic regression model. Results: Median free DNA concentration was ∼5-fold higher in patients than in healthy donors (P <0.001). The area under the ROC curve was 0.86, and when 12.5 ng/mL was used as cutoff, 81.3{\%} sensitivity and 73.3{\%} specificity were observed for the overall series. As CEA and free DNA provided independent diagnostic information, they were also considered in combination. ROC curve analysis of the combined CEA and free DNA algorithms showed a higher diagnostic capacity (area under the ROC curve, 0.92) than that of markers considered singly, with 84{\%} sensitivity and 88{\%} specificity. Conclusions: Free circulating DNA, especially when used in combination with CEA, represents a potentially useful tool for the diagnosis of early-stage colorectal cancer.",
author = "Emanuela Flamini and Laura Mercatali and Oriana Nanni and Daniele Calistri and Roberta Nunziatini and Wainer Zoli and Paola Rosetti and Nice Gardini and Arturo Lattuneddu and Verdecchia, {Giorgio Maria} and Dino Amadori",
year = "2006",
month = "12",
day = "1",
doi = "10.1158/1078-0432.CCR-06-1931",
language = "English",
volume = "12",
pages = "6985--6988",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - Free DNA and carcinoembryonic antigen serum levels

T2 - An important combination for diagnosis of colorectal cancer

AU - Flamini, Emanuela

AU - Mercatali, Laura

AU - Nanni, Oriana

AU - Calistri, Daniele

AU - Nunziatini, Roberta

AU - Zoli, Wainer

AU - Rosetti, Paola

AU - Gardini, Nice

AU - Lattuneddu, Arturo

AU - Verdecchia, Giorgio Maria

AU - Amadori, Dino

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Purpose: The identification of new molecular markers for the early detection of colorectal cancer has become an important objective. We compared the sensitivity and specificity of free circulating DNA with that of the more conventional carcinoembryonic antigen (CEA) and evaluated the two markers in combination. Experimental Design: The study was carried out on 75 healthy donors and 75 colorectal cancer patients. Free DNA was determined in serum with quantitative PCR analysis. The diagnostic accuracy of each assay was calculated using receiver operating characteristic (ROC) curves. The diagnostic relevance of the two-marker combination was analyzed by the logistic regression model. Results: Median free DNA concentration was ∼5-fold higher in patients than in healthy donors (P <0.001). The area under the ROC curve was 0.86, and when 12.5 ng/mL was used as cutoff, 81.3% sensitivity and 73.3% specificity were observed for the overall series. As CEA and free DNA provided independent diagnostic information, they were also considered in combination. ROC curve analysis of the combined CEA and free DNA algorithms showed a higher diagnostic capacity (area under the ROC curve, 0.92) than that of markers considered singly, with 84% sensitivity and 88% specificity. Conclusions: Free circulating DNA, especially when used in combination with CEA, represents a potentially useful tool for the diagnosis of early-stage colorectal cancer.

AB - Purpose: The identification of new molecular markers for the early detection of colorectal cancer has become an important objective. We compared the sensitivity and specificity of free circulating DNA with that of the more conventional carcinoembryonic antigen (CEA) and evaluated the two markers in combination. Experimental Design: The study was carried out on 75 healthy donors and 75 colorectal cancer patients. Free DNA was determined in serum with quantitative PCR analysis. The diagnostic accuracy of each assay was calculated using receiver operating characteristic (ROC) curves. The diagnostic relevance of the two-marker combination was analyzed by the logistic regression model. Results: Median free DNA concentration was ∼5-fold higher in patients than in healthy donors (P <0.001). The area under the ROC curve was 0.86, and when 12.5 ng/mL was used as cutoff, 81.3% sensitivity and 73.3% specificity were observed for the overall series. As CEA and free DNA provided independent diagnostic information, they were also considered in combination. ROC curve analysis of the combined CEA and free DNA algorithms showed a higher diagnostic capacity (area under the ROC curve, 0.92) than that of markers considered singly, with 84% sensitivity and 88% specificity. Conclusions: Free circulating DNA, especially when used in combination with CEA, represents a potentially useful tool for the diagnosis of early-stage colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=33845805706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845805706&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-06-1931

DO - 10.1158/1078-0432.CCR-06-1931

M3 - Article

C2 - 17145818

AN - SCOPUS:33845805706

VL - 12

SP - 6985

EP - 6988

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 23

ER -